Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| pt-A | ptAW37 | U.S. | 1995 | HIV1 | B | PBMC | MMC |
Treatment History
| Order | Regimen | Weeks |
| 1 | IDV | 37 |
Protease Sequence
| PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
| M46I, V82T, I84V | L24I | L10V, T12I, N37D, L63P, A71V |
| >ptAW37| 8 | codons 1-99 | clone 8 PQITLWQRPVVIIKIGGQLKEALIDTGADDTVLEEMDLPGRWKPKIIGGIGGFIKVRQYD QIPIEICGHKIIGTVLVGPTPTNVIGRNLLTQIGCTLNF >ptAW37| 7 | codons 1-99 | clone 7 PQITLWQRPVVIIKIGGQLKEALIDTGADDTVLEEMDLPGRWKPKIIGGIGGFIKVRQYD QIPIEICGHKVIGTVLVGPTPTNIIGRNLLTQIGCTLNF >ptAW37| 6 | codons 1-99 | clone 6 PQITLWQRPVVIIKIGGQLKEALIDTGADDTVLEEMDLPGRWKPKIIGGIGGFIKVRQYD QIPIEICGHKVIGTVLVGPTPTNVIGRNLLTQIGCTLNF >ptAW37| 5 | codons 1-99 | clone 5 PQITLWQRPVVIIKIGGQLKEALIDTGADDTVLEEMDLPGRWKPKIIGGIGGFIKVRQYD QIPIEICGHKVIGTVLVGPTPTNVIGRNLLTQIGCTLNF >ptAW37| 4 | codons 1-99 | clone 4 PQITLWQRPVVIIKIGGQLKEALIDTGADDTVLEEMDLPGRWKPKIIGGIGGFIKVRQYD QIPIEICGHKVIGTVLVGPTPTNVIGRNLLTQIGCTLNF >ptAW37| 3 | codons 1-99 | clone 3 PQITLWQRPVVIIKIGGQLKEALIDTGADDTVLEEMDLPGRWKPKIIGGIGGFIKVRQYD QIPIEICGHKVIGTVLVGPTPTNVIGRNLLTQIGCTLNF >ptAW37| 2 | codons 1-99 | clone 2 PQITLWQRPVVIIKIGGQLKEALIDTGADDTVLEEMDLPGRWKPKIIGGIGGFIKVRQYD QIPIEICGHKVIGTVLVGPTPTNVIGRNLLTQIGCTLNF >ptAW37| 1 | codons 1-99 | clone 1 PQITLWQRPVVIIKIGGQLKEALIDTGADDTVLEEMDLPGRWKPKIIGGIGGFVKVRQYD QIPIEICGHKVIGTVLVGPTPTNIIGRNLLTQIGCTLNF >ptAW37| codons 1-99 PQITLWQRPVVIIKIGGQLKEALIDTGADDTVLEEMDLPGRWKPKIIGGIGGFIKVRQYD QIPIEICGHKVIGTVLVGPTPTNVIGRNLLTQIGCTLNF |
References
| Author | Title | Citation |
| Condra, JH | Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. | J Virol, 1996 |
| Rhee, SY | HIV-1 Protease and Reverse Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance. | J Infect Dis, 2005 |